What Supplements Actually Have Evidence in Perimenopause and Menopause?

Perimenopause and postmenopause are related but not identical study populations. Trials also measure different outcomes: hot-flash frequency, symptom scores, sleep, bone density, fractures, lean mass, or strength. A result in one lane does not automatically transfer to another. ^{1 4}

This is why a single ranking of “best menopause supplements” is misleading. An ingredient used to fill a calcium or vitamin D gap is answering a bone-nutrition question. Creatine used alongside resistance training is answering a muscle question. Neither is evidence that a product relieves hot flashes or changes hormone levels.

The Menopause Society’s 2023 position statement did not recommend supplements or herbal remedies for hot flashes and night sweats. Its panel judged the evidence limited or inconsistent, and it separately did not recommend soy foods, soy extracts, or equol for this purpose. ¹

NICE’s current guideline retains a 2015 recommendation that there is some evidence that isoflavones or black cohosh may relieve vasomotor symptoms, while stressing that preparations vary, safety is uncertain, and medicine interactions have been reported. ²

A 2026 systematic review prepared to inform International Menopause Society recommendations found moderate-certainty evidence for black cohosh on selected symptom outcomes, but rated most complementary therapy evidence low or very low certainty overall. ⁴

Those conclusions are not interchangeable, but they are not evidence that one source is hiding an obvious cure. Reviews include different products, populations, outcomes, and evidence thresholds. “Not recommended” means the evidence did not meet that panel’s standard for a clinical recommendation. It is not proof that every study found exactly zero effect.

Soy foods, soy protein, soy germ extracts, purified isoflavones, and equol products are not the same intervention. NCCIH summarizes the hot-flash effect of soy isoflavone supplements as possible but small, while also noting that much of the underlying research is low quality. ³

A 2024 meta-analysis of five randomized trials and 425 participants did not find a statistically significant improvement in overall menopause symptoms or the physical and mental quality-of-life components. That does not erase every narrower hot-flash finding, but it does argue against presenting soy isoflavones as a reliable answer for the full menopause experience. The same analysis reported a reduction in depression scores, although the authors also flagged a high risk of conflict of interest in the included studies. ⁵

On a supplement label, the weight of a soy extract is not necessarily the amount of isoflavones. Look for the disclosed isoflavone amount, source material, full serving, and whether the product hides soy inside a blend. The Soy Isoflavones guide explains those distinctions in more detail.

Soy foods also should not be treated as equivalent to concentrated supplements when discussing long-term use or hormone-sensitive conditions. NCCIH considers the safety of soy isoflavone supplements uncertain for people with a history of or elevated risk for breast cancer, even though its summary distinguishes that uncertainty from ordinary soy foods. ³

Black cohosh is among the most studied menopause botanicals, but the research does not describe one uniform ingredient. Trials have used particular extracts and combination products. NCCIH reports a possible benefit for some preparations, alongside inconsistent findings across the wider category. ⁶

A useful label should identify black cohosh as Actaea racemosa, name the plant part, disclose the extract or powder form, state the individual amount, and show any declared standardization. Standardization can help identify the commercial preparation, but it does not guarantee the same clinical result as a different studied extract. See the full Black Cohosh label guide.

Red Clover is another source of isoflavones, but studies of menopause symptoms have been inconsistent. A red clover extract weight and a disclosed total-isoflavone amount are different label facts. Neither number proves a hot-flash response. ³

Product identity is also a safety issue. NCCIH notes rare reports of serious liver injury in people using products labeled as black cohosh, while causation remains uncertain, and reports that some commercial products contained the wrong herb or undeclared mixtures. ⁶

Bone loss accelerates around menopause, and both calcium and vitamin D are relevant to bone biology. That makes them important nutrients, but it does not make routine high-dose supplementation the answer for every person. Trials and reviews report mixed effects on bone density and fractures, especially in generally healthy community-dwelling adults. ^{7 8}

The relevant starting point is total intake, vitamin D status when clinically assessed, age, bone-health risk, and the reason a supplement is being considered. A nutrient gap and a menopause symptom are not the same problem.

On U.S. Supplement Facts panels, the listed calcium amount represents elemental calcium, while the source may appear in parentheses. Vitamin D may be shown in micrograms and IU. Read the full serving and total daily intake across products rather than comparing the front-label tablet or gummy count. The Calcium and Vitamin D3 guides cover those label details.

More is not automatically better. Excess vitamin D from supplements can cause hypercalcemia and hypercalciuria. Higher supplemental calcium intakes may increase kidney-stone risk, and combining calcium with vitamin D may increase certain adverse effects. A high percentage of Daily Value is not proof of a better menopause formula. ^{7, 8}

Creatine monohydrate does not target hot flashes. Its relevant lane is muscle, strength, and training. A 2026 meta-analysis of seven randomized trials in postmenopausal women found small average gains in lean mass and leg-press strength, mainly in studies pairing at least 5 g per day with resistance training. Bone density was unchanged overall. ⁹

The review also had limits: most trials had some risk-of-bias concerns, the review was not prospectively registered, and industry relationships or publication support were disclosed. That does not nullify the result, but it keeps a small pooled effect from becoming a universal promise.

A label comparison should start with creatine form, grams per complete serving, serving instructions, and blend transparency. “For women” or “menopause strength” does not establish a distinct creatine molecule. Read the Creatine for Women guide and the Creatine Monohydrate ingredient guide for the full label context.

Sleep problems during the menopause transition can occur alongside hot flashes, mood symptoms, pain, sleep disorders, medicines, and ordinary life stress. A magnesium or melatonin label does not identify which factor is driving a particular person’s sleep problem.

Magnesium has general sleep research, but systematic reviews describe the randomized evidence as limited or uncertain, and it is not an established menopause-specific treatment. Its clearer role is as an essential nutrient when intake is inadequate, not as proof that a “menopause sleep” blend will work. ¹⁰

Similar caution applies to B vitamins, adaptogens, mushroom extracts, and “brain fog” combinations. Correcting a documented deficiency is a different claim from improving cognition, mood, or fatigue in everyone going through perimenopause. The label can disclose ingredients and amounts. It cannot diagnose the cause of a symptom.

A formula with ten familiar ingredients is not automatically better supported than a transparent single-ingredient product. Evidence is ingredient-, preparation-, amount-, population-, and outcome-specific. “Clinically studied ingredients” does not mean the finished formula was studied.

The practical job is to translate the Supplement Facts panel into separate questions. That is especially important when a product mixes botanicals, nutrients, sleep ingredients, and hormone-adjacent claims in one serving.